J. X. Lima Neto

A quantum biochemistry investigation of willardiine partial agonism in AMPA receptors.

E. L. Albuquerque, E. Albuquerque, E. Caetano, 2015, Physical chemistry chemical physics : PCCP.

Interaction energies between two antiandrogenic and one androgenic agonist receptor in the presence of a T877A mutation in prostate cancer: a quantum chemistry analysis

E. L. Albuquerque, E. Albuquerque, U. L. Fulco, 2020 .

First-principles study of solid-state properties of adrenergic neurotransmitters, orthorhombic noradrenaline, and monoclinic adrenaline

U. L. Fulco, R. Tromer, J. X. Lima Neto, 2021 .

Ribosomal RNA-Aminoglycoside Hygromycin B Interaction Energy Calculation within a DFT Framework.

E. L. Albuquerque, L. Machado, V. Freire, 2019, The journal of physical chemistry. B.

Blockade of the checkpoint PD-1 by its ligand PD-L1 and the immuno-oncological drugs pembrolizumab and nivolumab.

E. L. Albuquerque, U. L. Fulco, J. X. Lima Neto, 2021, Physical chemistry chemical physics : PCCP.

A quantum biochemistry approach to investigate checkpoint inhibitor drugs for cancer

E. L. Albuquerque, U. L. Fulco, J. X. Lima Neto, 2019, New Journal of Chemistry.

Inhibition of the checkpoint protein PD-1 by the therapeutic antibody pembrolizumab outlined by quantum chemistry

E. L. Albuquerque, U. L. Fulco, J. X. Lima Neto, 2018, Scientific Reports.

Quantum Biochemical Investigation of Lys49-PLA2 from Bothrops moojeni.

L. Machado, U. L. Fulco, J. X. Lima Neto, 2021, The journal of physical chemistry. B.

Inhibition of the checkpoint protein PD-1 by the therapeutic antibody pembrolizumab outlined by quantum chemistry

E. L. Albuquerque, U. L. Fulco, J. X. Lima Neto, 2018, Scientific Reports.